Last edition
News about "GSK collaborates with Medicago adjuvanted COVID-19"
GSK collaborates with Medicago to develop novel adjuvanted COVID-19 candidate vaccine
GSK and Medicago, a biopharmaceutical company, announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago's recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK's pandemic adjuvant system
GSK Collaborates With Medicago Adjuvanted COVID-19 | 09/07/2020 | By Darshana | 417
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members